Cue Biopharma, Inc. ( CUE) - Key Metrics
CUE Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $1.24 | -$24.14 | -$4.57 | -$4.57 |
| 2026Q1 | $1.18 | -$1.08 | -$2.28 | -$2.30 |
| 2025Q4 | $6.10 | $0.44 | -$0.30 | -$0.30 |
| 2025Q3 | $0.64 | -$2.22 | -$2.68 | -$2.68 |
| 2025Q2 | $0.93 | -$2.67 | -$1.07 | -$1.08 |
CUE Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.33 |
| 2026Q1 | 0% | -1.60 |
| 2025Q4 | 0% | 5.20 |
| 2025Q3 | 0% | -2.43 |
| 2025Q2 | 0% | -1.92 |
CUE
Price: $18.67
52 week price:
Earnings Per Share: -28.42 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 255300
Market Capitalization: 168.1 million